Erythrocyte deformability correlates with systemic inflammation
Blood Cells, Molecules, and Diseases · 2024
DOI: 10.1016/j.bcmd.2024.102881 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Blood Cells, Molecules, and Diseases, 2024. Verfasst von Carmen Jacob und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Neurosciences, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, UK; Wessex Neurological Centre, Universit…. Hauptthemen laut MEDLINE: Erythrocyte Deformability, Inflammation, C-Reactive Protein. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, UKRI Medical Research Council, National Institute for Health and Care Research.
Abstract (Originalsprache)
Recent evidence suggests that systemic conditions, particularly those associated with inflammation, can affect erythrocyte deformability in the absence of haematological conditions. In this exploratory study, we investigated the relationship between systemic inflammatory status and erythrocyte deformability (using osmotic gradient ektacytometry) in a heterogenous study population consisting of individuals with no medical concerns, chronic conditions, and acute illness, providing a wide range of systemic inflammation severity. 22 participants were included in a prospective observational study. Maximum Elongation Index (EImax) in ektacytometry served as the readout for erythrocyte deformability. Inflammatory status was assessed using C-reactive protein (CRP) and self-reported symptoms associated with inflammatory activation (Sickness Questionnaire Scores, SicknessQ). In a univariate linear regression, both CRP and SicknessQ scores significantly predicted EImax (CRP: F(1,20) = 7.751, p < 0.05 (0.011), R2 = 0.279; SicknessQ: F(1,18) = 4.831, p < 0.05 (0.041), R2 = 0.212). Sensitivity analyses with multivariable linear regression correcting for age showed concordant findings. Results suggest a linear relationship between erythrocyte deformability and biochemical and clinical markers of systemic inflammation. Replication of findings in a larger study, and mechanisms and clinical consequences need further in investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Neurosciences, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, UK; Wessex Neurological Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK. Electron…
- Haematology Department, Oxford University Hospitals NHS Trust, Oxford, England, UK.
- Clinical Neurosciences, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, UK; Wessex Neurological Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
- Wessex Neurological Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
- Clinical Neurosciences, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, UK.
Förderung
- Medical Research Council
- UKRI Medical Research Council
- National Institute for Health and Care Research
Zitieren
APA
Jacob, C., Piyasundara, L., Bonello, M., Nathan, M., Kaninia, S., Varatharaj, A., Roy, N., & Galea, I. (2024). Erythrocyte deformability correlates with systemic inflammation. Blood Cells, Molecules, and Diseases. https://doi.org/10.1016/j.bcmd.2024.102881
Vancouver
Jacob C, Piyasundara L, Bonello M, Nathan M, Kaninia S, Varatharaj A, et al. Erythrocyte deformability correlates with systemic inflammation. Blood Cells, Molecules, and Diseases. 2024. doi:10.1016/j.bcmd.2024.102881
BibTeX
@article{Jacob2024,
author = {Jacob, Carmen and Piyasundara, Lakeesha and Bonello, Maria and Nathan, Michael and Kaninia, Stefania and Varatharaj, Aravinthan and Roy, Noémi and Galea, Ian},
title = {Erythrocyte deformability correlates with systemic inflammation},
journal = {Blood Cells, Molecules, and Diseases},
year = {2024},
doi = {10.1016/j.bcmd.2024.102881}
}
EUVIMED